Triastek

Provider of 3D printing pharmaceutical technology platform for drug design

placeNanjing, Jiangsu, China calendar_todayFounded 2015 groups46 employees language triastek.com

Social engagement

Social engagement: 2.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Morningside, Matrix Partners China, CPE, Dalton Venture.

Investor typeCountShare
Venture capital646%
Private equity18%
Other / undisclosed646%

Recent activity

5 Jun 2026
Event
Industrial Insights into Pharmaceutical 3D Printing
27 May 2026
Event
Industrial Insights into Pharmaceutical 3D Printing
31 Mar 2026
Event
15th PBP World Meeting
Coming soon